Clinical Trials Logo

LUTS clinical trials

View clinical trials related to LUTS.

Filter by:
  • None
  • Page 1

NCT ID: NCT04891926 Completed - Menopause Clinical Trials

Hormonal Influences on Diuresis

HODI
Start date: May 1, 2015
Phase: N/A
Study type: Interventional

The aim of this study was to observe the effect of hormonal treatment (oral or transdermal substitution therapy) on diuresis (salt and water diuresis) and lower urinary tract symptoms (LUTS) in postmenopausal women

NCT ID: NCT04148677 Not yet recruiting - Pain Clinical Trials

Protoves M1® Syrup in Controlling Adverse Event During HIVEC® Instillations

Start date: December 1, 2019
Phase:
Study type: Observational

100 patients with bladder cancer whose underwent Hyperthermic Intravesical Chemotherapy (HIVEC®) will be randomized in two groups (Group A: PROTOVES M1 SYRUP, Group B: NO TREATMENT). The aim of this study will be to analyse the role of two alkaloid, Protopine and Nuciferine (Protoves-M1 ®) in the prevention and the treatment of the low and mild grade adverse events related to the use of HIVEC® instillations.

NCT ID: NCT02447367 Completed - Overactive Bladder Clinical Trials

Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers

Start date: July 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the pharmacokinetic drug interaction between Solifenacin and Tamsulosin in healthy male volunteers.

NCT ID: NCT02180997 Completed - Overactive Bladder Clinical Trials

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

Start date: July 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the pharmacokinetic drug interaction between Solifenacin and Tamsulosin in healthy male volunteers.

NCT ID: NCT01846793 Completed - Clinical trials for Benign Prostatic Hyperplasia

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

Start date: April 2013
Phase: Phase 3
Study type: Interventional

This study is designed to demonstrate the safety and efficacy of a second transrectal intraprostatic injection of NX-1207 given to subjects with Benign Prostatic Hyperplasia (BPH) who previously received an injection of NX-1207 in an earlier U.S. clinical trial of NX-1207.